Logo-bi
Bioimpacts. 2025;15: 31475 | Published on: 2025 Nov 10. doi: 10.34172/bi.31475

Review

Allosteric ligand-driven smart nanoconjugates for mutation-selective EGFR targeting: A precision approach to overcoming tyrosine kinase inhibitor resistance

Dilpreet Singh 1 * ORCID, Akshay Kumar 1, Vir Vikram Sharma 1

Cited by CrossRef:



As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMedPubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science IndicatorsEmbase; EBSCOhost; CAS: DOAJSHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons